Filing Details
- Accession Number:
- 0001181431-13-000828
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-03 14:37:53
- Reporting Period:
- 2012-12-31
- Filing Date:
- 2013-01-03
- Accepted Time:
- 2013-01-03 14:37:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1492426 | Horizon Pharma Inc. | HZNP | Pharmaceutical Preparations (2834) | 272179987 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1523386 | Michael Adatto | C/O Horizon Pharma, Inc. 520 Lake Cook Road, Suite 520 Deerfield IL 60015 | Svp, Managed Care & Comm. Dev. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-12-31 | 22,500 | $0.00 | 29,909 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2013-01-02 | 6,998 | $2.36 | 22,911 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee stock options (right to buy) | Acquisiton | 2013-01-02 | 21,750 | $0.00 | 21,750 | $2.40 |
| Common Stock | Restricted stock units | Acquisiton | 2013-01-02 | 19,800 | $0.00 | 19,800 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 21,750 | 2023-01-01 | No | 4 | A | Direct | |
| 19,800 | No | 4 | A | Direct |
Footnotes
- On January 3, 2012, the reporting person was granted restricted stock units which vest upon the achievement of certain performance criteria. On December 31, 2012, 22,500 of these restricted stock units vested in connection with the achievement of certain of these performance related goals. No unvested restricted stock units with respect to this grant were outstanding after the completion of this transaction.
- Includes 2,910 shares of the Company's common stock acquired pursuant to an employee stock purchase program.
- Reflects shares of common stock surrendered via open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in December 2012, in order to satisfy certain tax withholding obligations.
- The shares subject to the option vest and become exercisable in forty-eight equal monthly installments from the vesting commencement date of January 2, 2013.
- Each restricted stock unit represents a contingent right to receive one share of Horizon Pharma, Inc. common stock.
- The restricted stock units vest in four equal annual installments beginning January 2, 2014.
Billionaire Hedge Funds
